Targeting the Heme Oxygenase 1/Carbon Monoxide Pathway to Resolve Lung Hyper-Inflammation and Restore a Regulated Immune Response in Cystic Fibrosis
In individuals with cystic fibrosis (CF), lung hyper-inflammation starts early in life and is perpetuated by mucus obstruction and persistent bacterial infections. The continuous tissue damage and scarring caused by non-resolving inflammation leads to bronchiectasis and, ultimately, respiratory fail...
Main Authors: | Caterina Di Pietro, Hasan H. Öz, Thomas S. Murray, Emanuela M. Bruscia |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.01059/full |
Similar Items
-
Heme oxygenase-1 and carbon monoxide in pulmonary medicine
by: Choi Augustine MK, et al.
Published: (2003-08-01) -
Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury
by: Maria G. Detsika, et al.
Published: (2021-01-01) -
Carbon Monoxide (CO) as a Retinal Regulator of Heme Oxygenases -1, and -2 (HO’s) Expression
by: Sławomir Nowak, et al.
Published: (2022-02-01) -
Adaptive Potential of the Heme Oxygenase/Carbon Monoxide Pathway During Hypoxia
by: Michael S. Tift, et al.
Published: (2020-07-01) -
Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly?
by: Ditte M. S. Lundvig, et al.
Published: (2012-05-01)